21-648 Phase I
Phase 1 trial of intravenous administration of TAEKVAC- HerBy vaccine alone and in combination with HER2 antibodies in patients with advanced cancer (View details on clinicaltrial.gov)
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Phase 1 trial of intravenous administration of TAEKVAC- HerBy vaccine alone and in combination with HER2 antibodies in patients with advanced cancer (View details on clinicaltrial.gov)